A real-world data-driven approach to optimizing enoxaparin dosing in burn patients基于真实世界数据的肝素优化给药方案在烧伤患者中的应用British Journal of Clinical PharmacologyIF32025-11-230OAAI
Low Anti-Factor Xa Level Predicts 90-Day Symptomatic Venous Thromboembolism in Surgical Patients Receiving Enoxaparin Prophylaxis A Pooled Analysis of Eight Clinical TrialsANNALS OF SURGERYIF6.42020-10-1911OA
Assessment of Anti-Factor Xa Levels of Patients Undergoing Colorectal Surgery Given Once-Daily Enoxaparin Prophylaxis: A Clinical Study Examining Enoxaparin PharmacokineticsJAMA SURGERYIF14.92019-08-0127OAAI
Enoxaparin 40 mg per Day Is Inadequate for Venous Thromboembolism Prophylaxis After Thoracic Surgical ProcedureANNALS OF THORACIC SURGERYIF3.92018-08-0128OAAI
The Impact of Once- versus Twice-Daily Enoxaparin Prophylaxis on Risk for Venous Thromboembolism and Clinically Relevant BleedingPLASTIC AND RECONSTRUCTIVE SURGERYIF3.42018-07-0130PREAI
Twice-Daily Enoxaparin among Plastic Surgery Inpatients: An Examination of Pharmacodynamics, 90-Day Venous Thromboembolism, and 90-Day BleedingPLASTIC AND RECONSTRUCTIVE SURGERYIF3.42018-06-0118PREAI
LONG-TERM USE OF HIGH-DOSE LOPERAMIDE LEADING TO CARDIAC ARREST AND VENTRICULAR ARRHYTHMIASCRITICAL CARE MEDICINEIF62018-01-010PREAI
EVALUATION OF MEROPENEM CONTINUOUS-INFUSION CLEARANCE IN BURN PATIENTSCRITICAL CARE MEDICINEIF62018-01-010PREAI
Weight-Based Dosing for Once-Daily Enoxaparin Cannot Provide Adequate Anticoagulation for Venous Thromboembolism ProphylaxisPLASTIC AND RECONSTRUCTIVE SURGERYIF3.42017-10-0114PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向